IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brad C. Dunlap who wrote (186)	12/8/1996 10:13:00 PM
From: I. Luttichuys	of 1762

Hello Brad, I am very appreciative that you found the time to post this evening and I am excited about the content. We had discussed the eventuality of IDEC-C2B8 as a therapy for CLL and it appears this is something we will see a trial on. I am impressed that Dr. Rai has suggested this possibility as therapy so we may one day see C2B8 in this role. We are getting a very interesting pipe-line here. Although you have not seen Monday's presentation, it sounds like we have nothing to contradict the efficacies shown in previous posts. As far as timing of FDA approval, IDEC is of course wise not to attempt naming dates. I might add that it has been my experience (and I believe you had mentioned yours also) that IDEC's statements of this nature can be viewed as meaning they are where they say they are or even closer. I will then expect FDA decision some time after the summer. The oncologists you have spoken to seem to view C2B8's front-line use with the same eye I do, which is to say that all things panning out as expected it would seem a natural choice. I do thank you for the post. Hope you are enjoying your evening, BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next